Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Mohammed Nabil Quraishi"'
Autor:
Hannah Crothers, James Ferguson, Mohammed Nabil Quraishi, Rachel Cooney, Tariq H. Iqbal, Palak J. Trivedi
Publikováno v:
The Lancet Regional Health. Europe, Vol 44, Iss , Pp 101002- (2024)
Summary: Background: Primary sclerosing cholangitis (PSC) is one of the leading indications for liver transplantation in Europe, and a major risk factor for cancer in inflammatory bowel disease (IBD). However, it is not known how the epidemiology of
Externí odkaz:
https://doaj.org/article/842f71d61ecd4b9d9faa9412abe8887b
Autor:
Aditi Kumar, Mohammed Nabil Quraishi, Hafid O. Al-Hassi, Mohammed E. El-Asrag, Jonathan P. Segal, Manushri Jain, Helen Steed, Jeffrey Butterworth, Adam Farmer, John Mclaughlin, Andrew Beggs, Matthew J. Brookes
Publikováno v:
Frontiers in Microbiology, Vol 14 (2023)
IntroductionBile acid diarrhoea (BAD) is a common disorder that results from an increased loss of primary bile acids and can result in a change in microbiome. The aims of this study were to characterise the microbiome in different cohorts of patients
Externí odkaz:
https://doaj.org/article/cd4761a409274587af0e9a8c3d696cb4
Autor:
Sofie Bosch, Animesh Acharjee, Mohammed Nabil Quraishi, Irene V Bijnsdorp, Patricia Rojas, Abdellatif Bakkali, Erwin EW Jansen, Pieter Stokkers, Johan Kuijvenhoven, Thang V Pham, Andrew D Beggs, Connie R Jimenez, Eduard A Struys, Georgios V Gkoutos, Tim GJ de Meij, Nanne KH de Boer
Publikováno v:
Gut Microbes, Vol 14, Iss 1 (2022)
Background Screening for colorectal cancer (CRC) reduces its mortality but has limited sensitivity and specificity. Aims We aimed to explore potential biomarker panels for CRC and adenoma detection and to gain insight into the interaction between gut
Externí odkaz:
https://doaj.org/article/7b47430b742b473c9f1e78bcdb4e406c
Autor:
Nia Paddison Rees, Walaa Shaheen, Christopher Quince, Chris Tselepis, Richard D Horniblow, Naveen Sharma, Andrew D Beggs, Tariq H Iqbal, Mohammed Nabil Quraishi
Publikováno v:
EBioMedicine, Vol 81, Iss , Pp 104088- (2022)
Summary: Background: Faecal microbiota transplantation (FMT) has previously been explored as a treatment for ulcerative colitis (UC) however, biomarkers that predict and / or are associated with clinical response are poorly defined. The aim of this s
Externí odkaz:
https://doaj.org/article/09fb49a9c652447c98c3d60b21bf6f3e
Autor:
Mehmet Yalchin, Jonathan P. Segal, Benjamin H. Mullish, Mohammed Nabil Quraishi, Tariq H. Iqbal, Julian R. Marchesi, Ailsa L. Hart
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 12 (2019)
Faecal microbiota transplant (FMT) has now been established into clinical guidelines for the treatment of recurrent and refractory Clostridioides difficile infection (CDI). Its therapeutic application in inflammatory bowel disease (IBD) is currently
Externí odkaz:
https://doaj.org/article/e557e6d5e4ce486099d64e34576e7689
Autor:
Jonathan P. Segal, Benjamin H. Mullish, Mohammed Nabil Quraishi, Animesh Acharjee, Horace R. T. Williams, Tariq Iqbal, Ailsa L. Hart, Julian R. Marchesi
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 12 (2019)
The aetiopathogenesis of inflammatory bowel diseases (IBD) involves the complex interaction between a patient’s genetic predisposition, environment, gut microbiota and immune system. Currently, however, it is not known if the distinctive perturbati
Externí odkaz:
https://doaj.org/article/447431621e9a4a239c52f1537acfbaaa
Publikováno v:
Gastroenterology Research and Practice, Vol 2016 (2016)
Externí odkaz:
https://doaj.org/article/72447f5fdeff4da4a93ed76b6037f28a
Publikováno v:
Clin Exp Immunol
Summary Autoimmune diseases have long been known to share a common pathogenesis involving a dysregulated immune system with a failure to recognize self from non-self-antigens. This immune dysregulation is now increasingly understood to be induced by
Autor:
Yakup Kilic, Shahed Kamal, Farah Jaffar, Danujan Sriranganathan, Mohammed Nabil Quraishi, Jonathan P Segal
Publikováno v:
Inflammatory Bowel Diseases.
Background Inflammatory bowel disease (IBD) is a multisystem disease impacting various body systems including musculoskeletal, ocular, skin, hepatobiliary, pulmonary, cardiac, and haematological systems. The extraintestinal manifestations of IBD are
Publikováno v:
Frontline Gastroenterol
Vedolizumab is a gut-selective monoclonal antibody approved for the management of Crohn’s disease and ulcerative colitis. The available data demonstrate a favourable response to dose escalation in patients with primary non-response or secondary los